SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) Sees Unusually-High Trading Volume – Time to Buy?

SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) saw unusually-high trading volume on Monday. 145,914 shares changed hands during trading, an increase of 46% from the previous session’s volume of 100,158 shares. The stock last traded at $66.16 and had previously closed at $66.09.

SPDR S&P Pharmaceuticals ETF Stock Up 1.0%

The company has a market cap of $550.69 million, a PE ratio of 14.28 and a beta of 0.59. The business has a 50-day simple moving average of $69.59 and a 200-day simple moving average of $62.72.

Hedge Funds Weigh In On SPDR S&P Pharmaceuticals ETF

Institutional investors and hedge funds have recently bought and sold shares of the business. Turtle Creek Wealth Advisors LLC purchased a new stake in shares of SPDR S&P Pharmaceuticals ETF in the first quarter valued at approximately $26,000. Western Wealth Management LLC acquired a new stake in SPDR S&P Pharmaceuticals ETF during the first quarter worth about $34,000. Fifth Third Bancorp acquired a new position in SPDR S&P Pharmaceuticals ETF in the 1st quarter valued at about $39,000. TD Waterhouse Canada Inc. acquired a new stake in shares of SPDR S&P Pharmaceuticals ETF during the 2nd quarter worth approximately $200,000. Finally, Corient Private Wealth LP purchased a new stake in shares of SPDR S&P Pharmaceuticals ETF during the 2nd quarter valued at approximately $225,000.

About SPDR S&P Pharmaceuticals ETF

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.